Herpes Simplex - 31 Studies Found
| Completed |
: Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease : Herpes Simplex : 2008-06-17 :
|
| Completed |
: Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection : Herpes Simplex : 2007-03-15 : Drug: famciclovir Administered orally as a single individualized dose between 25-200 mg based on body we |
| Completed |
: Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old : Herpes Simplex : 2005-09-21 :
|
| Completed |
: Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects : Prophylaxis for Herpes Simplex : 2008-06-16 :
|
| Completed |
: Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine : Herpes Simplex : 2005-09-21 : Biological: GSK208141 vaccine 3 IM doses Other Name: |
| Completed |
: Valaciclovir to Prevent Transmission of Herpes Simplex Virus : Herpes Simplex : 1999-11-03 : Drug: Valaciclovir |
| Completed |
: Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection : Herpes Simplex : 2004-12-02 : Drug: Famciclovir Famciclovir sprinkle capsules, 25 mg and 100 mg, using OraSweet® syrup vehicle |
| Completed |
: Open-label Study of ASP2151 in Herpes Simplex Patients : Herpes Simplex : 2014-07-31 : Drug: ASP2151 Other Name: 200 mg once daily |
| Completed |
: Phase III Study of ASP2151 in Herpes Simplex Patients : Herpes Simplex : 2013-09-26 :
|
| Completed |
: Herpes Simplex Reactivation in Adult Critical Care Patients :
|